Analysts' New Coverage for May 15th (ACOR, AER, AL, AXR, BSQR, CLRO, CPSH, CYD, DHC, ELXXF)

Analysts’ new coverage for Monday, May 15th: StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. Citigroup Inc. initiated coverage on shares of AerCap (NYSE:AER). The firm issued a buy rating and a $71.00 price target on the stock. Citigroup Inc. initiated coverage on shares of […]

Related Keywords

Switzerland ,Canada , ,Switzerland Group ,Liqtech International ,Royal Bank ,Healthcare Trust ,Global Indemnity Group ,Oppenheimer Holdings Inc ,Elixirr International ,China Yuchai International ,Titan Pharmaceuticals ,Factset Research Systems ,Novabay Pharmaceuticals ,Mexco Energy ,Citigroup Inc ,Marin Software ,Origin Enterprises ,Canaccord Genuity Group Inc ,News Ratings For Acorda Therapeutics Inc Daily ,Sigmatron International ,Acorda Therapeutics Inc ,Acorda Therapeutics ,Air Lease ,Diversified Healthcare Trust ,Milestone Scientific ,Navidea Biopharmaceuticals ,Genuity Group ,Odyssey Marine Exploration ,Oncternal Therapeutics ,Pretium Resources ,Oppenheimer Holdings ,World Wrestling Entertainment ,Acorda Therapeutics Inc Daily ,Aercap Holdings ,Air Lease Co ,Amrep Co ,Bsquare Co ,Clearone Inc ,Cps Technologies Co ,China Yuchai International Limited ,Elixirr International Plc ,